Acellular matrix material as well as preparation method and application thereof
By decellularizing treatment in carbon dioxide ionic liquid and combining enzymatic lysis and hyaluronic acid/antibacterial peptide complex reaction, a decellularized matrix material with excellent biocompatibility and mechanical properties was prepared, which solved the rapid degradation rate and mechanical properties of traditional materials. Good problems, reduce immune response and promote wound healing.
Patent Information
- Application Number
- CN202411108244.1
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-13
- Publication Date
- 2024-11-22
AI Technical Summary
Traditional decellularized matrix materials have a fast degradation rate, are unregulated, have poor mechanical properties, which are prone to inflammatory responses, and have problems of insufficient immunogenicity and biological activity.
After pretreatment of pig skin, decellularization is used in carbon dioxide ion liquid, and combined with enzymatic lysis and hyaluronic acid/antibacterial peptide complex reaction, a decellularized matrix material with excellent biocompatibility and low immunogenicity is prepared, through EDC and NHS activation reaction improves the crosslinkability and mechanical strength of the material.
It significantly reduces the degradation rate of the material, improves mechanical properties, reduces immune response and inflammatory response, enhances anti-inflammatory, antibacterial and anti-infective effects, and promotes wound healing.
Smart Images

Figure BDA0004991433050000141 
Figure BDA0004991433050000151 
Figure BDA0004991433050000152
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of new materials, and in particular to a decellularized matrix material and a preparation method and application thereof. Background Art
[0002] Decellularized matrix biomaterials are a new type of biomaterial that uses appropriate methods to decellularize tissues / organs, remove cells and other antigenic molecules in the tissues that may cause rejection reactions, retain three-dimensional structures and functional proteins, have biological induction functions, can form specific functionalized tissues in vivo / in vitro, and can be used for tissue damage repair / reconstruction. At present, the most widely used decellularized biomaterials are mainly xenogeneic decellularized matrices. The raw materials of this type of natural biomaterials are mainly derived from animal small intestinal submucosa, bladder submucosa, gastric submucosa, pericardium, peritoneum and dermis. Decellularized matrix biomaterials are widely used in the medical field. Compared with non-absorbable materials or traditional polymer materials, they have the ability to induce tissue regeneration, so they are considered to be ideal tissue repair materials. However, animal-derived biomaterials also have some risks. On the one hand, the exogenous residual DNA, fat and other immunogenic substances they carry may cause immune reactions after implantation in the human body; on the other hand, the reagents used in their processing process easily destroy the three-dimensional structure of the extracellular matrix, causing it to lose its ability to induce tissue regeneration in vivo. In addition, a common problem of decellularized matrix materials is that their mechanical properties are insufficient, and their degradation rate is fast and uncontrollable.
[0003] Regarding the effective active ingredients in the decellularized matrix, the effective active ingredients retained in the decellularized matrix vary greatly due to the use of different decellularization reagents or methods. The decellularization methods in the prior art mainly include: 1) physical method: such as the repeated freeze-thaw method, which belongs to the physical method for decellularization treatment. Because the cycle required is too long, it is basically no longer used; 2) chemical method: mainly acid, alkali, and detergent (also called surfactant), detergents such as SDS, Triton X-100, CHAPS, all of which are chemically synthesized or semi-synthetic, with strong detergency and good decellularization effect. However, the biological patches prepared using this type of decellularization reagent usually retain less effective active ingredients and the three-dimensional structure of the extracellular matrix is greatly damaged, so its ability to induce tissue regeneration is poor. On the other hand, the residual processing aids will cause cytotoxicity, irritation and immune response, thereby affecting the tissue repair effect. Summary of the invention
[0004] The purpose of the present invention is to propose a decellularized matrix material and a preparation method and application thereof, which has low cost, wide raw material sources, and a simple preparation method. It overcomes the problems of traditional decellularized matrix materials such as fast and uncontrollable degradation rate, poor mechanical properties, and easy to induce inflammatory response. It has excellent biocompatibility, low immunogenicity and biological activity, reduces the degradation rate of the product, and improves the mechanical strength of the product.
[0005] The technical solution of the present invention is achieved in this way:
[0006] The invention provides a method for preparing a cell-free matrix material. The method comprises the following steps: pre-treating pig skin, decellularizing the pig skin in an ionic liquid into which carbon dioxide is introduced, removing surface antigens by enzymatic hydrolysis, and reacting the pig skin with a ferulic acid and hyaluronic acid / antimicrobial peptide complex to prepare the cell-free matrix material.
[0007] As a further improvement of the present invention, the following steps are included:
[0008] S1. Pretreatment of pigskin: The pigskin is washed, depilated, cleaned, the epidermal stratum corneum and subcutaneous fat layer are removed, the dermis is cut into appropriate sizes, and soaked and shaken with 2-4% sodium hydroxide for 3-10 hours to obtain a pretreated pigskin material;
[0009] S2. Decellularization: adding the pretreated pig skin material to the ionic liquid, introducing carbon dioxide, stirring, dialyzing, and freeze-drying to obtain a decellularized dermal matrix;
[0010] S3. Enzymatic treatment: adding the acellular dermal matrix to water, adding α-galactosidase and trypsin, heating for enzymatic hydrolysis, filtering, washing, and drying to obtain the antigen-free acellular dermal matrix;
[0011] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: adding hyaluronic acid to water, adding EDC (1-ethyl-(3-dimethylaminopropyl) carbodiimide) and NHS (N-hydroxysuccinimide), activating the reaction, adding antimicrobial peptide, stirring the reaction, dialyzing, and freeze-drying to obtain a hyaluronic acid / antimicrobial peptide complex;
[0012] S5. Preparation of decellularized matrix material: ferulic acid and deantigenized decellularized dermal matrix are mixed and added into water, EDC and NHS are added to activate the reaction, hyaluronic acid / antimicrobial peptide complex is added, stirred for reaction, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0013] As a further improvement of the present invention, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid in step S2 is 1:7-10 g / mL, the ventilation volume of the carbon dioxide is 20-30 mL / min, the stirring treatment time is 1-2 h, and the ionic liquid is selected from at least one of acetic acid-3-methylimidazolium hexafluorophosphate, 1-propyl-3-methylimidazolium hexafluorophosphate, boron pentafluoride anthraquinone ionic liquid, N-butylpyridinium tetrafluoroborate, 4-carbamimidazolidine hydrochloride, pyridine p-toluenesulfonate, 1-butyl-2,3-dimethylimidazolium hexafluorophosphate, and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate.
[0014] As a further improvement of the present invention, the ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:3-5.
[0015] As a further improvement of the present invention, in step S3, the mass ratio of the acellular dermal matrix, α-galactosidase and trypsin is 100:3-5:2-3, the temperature of the heating enzymatic hydrolysis is 35-38° C., and the time is 2-4 h.
[0016] As a further improvement of the present invention, the mass ratio of hyaluronic acid, EDC, NHS and antimicrobial peptide in step S4 is 10:4-6:2-3:5-7, the temperature of the activation reaction is 20-25°C, the time is 30-60 min, and the stirring reaction time is 12-15 h.
[0017] As a further improvement of the present invention, the mass ratio of ferulic acid, antigen-free acellular dermal matrix, EDC, NHS, and hyaluronic acid / antimicrobial peptide complex in step S5 is 2-4:12-15:6-8:3-4:7-9, the temperature of the activation reaction is 0-4°C, the time is 30-50 min, and the stirring reaction time is 20-24 h.
[0018] As a further improvement of the present invention, the present invention specifically comprises the following steps:
[0019] S1. Pretreatment of pigskin: The pigskin is washed, depilated, cleaned, the epidermal stratum corneum and subcutaneous fat layer are removed, the dermis is cut into appropriate sizes, and soaked and shaken with 2-4% sodium hydroxide for 3-10 hours to obtain a pretreated pigskin material;
[0020] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, wherein the solid-liquid ratio of the pretreated pigskin material to the ionic liquid was 1:7-10 g / mL, carbon dioxide was introduced, the ventilation volume was 20-30 mL / min, the treatment was stirred for 1-2 h, dialyzed, and freeze-dried to obtain acellular dermal matrix;
[0021] S3. Enzymatic hydrolysis: 100 parts by weight of the acellular dermal matrix is added to water, 3-5 parts by weight of α-galactosidase and 2-3 parts by weight of trypsin are added, heated to 35-38° C., enzymatic hydrolysis is performed for 2-4 hours, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0022] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: add 10 parts by weight of hyaluronic acid to water, add 4-6 parts by weight of EDC and 2-3 parts by weight of NHS, activate and react at 20-25°C for 30-60 minutes, add 5-7 parts by weight of antimicrobial peptide, stir and react for 12-15 hours, dialyze, and freeze-dry to obtain a hyaluronic acid / antimicrobial peptide complex;
[0023] S5. Preparation of decellularized matrix material: Mix 2-4 parts by weight of ferulic acid and 12-15 parts by weight of de-antigenized decellularized dermal matrix and add into water, add 6-8 parts by weight of EDC and 3-4 parts by weight of NHS, activate and react at 0-4°C for 30-50 min, add 7-9 parts by weight of hyaluronic acid / antimicrobial peptide complex, stir and react for 20-24 h, dialyze, and freeze-dry to obtain the decellularized matrix material.
[0024] The present invention further protects a decellularized matrix material obtained by the above-mentioned preparation method.
[0025] The present invention further protects a use of the above-mentioned decellularized matrix material in the preparation of medical beauty products.
[0026] The present invention has the following beneficial effects:
[0027] The present invention prepares a decellularized matrix material, which overcomes the problems of traditional decellularized matrix materials such as fast and uncontrollable degradation rate, poor mechanical properties, and easy induction of inflammatory response.
[0028] The present invention first pre-treats the pigskin to obtain the pigskin material of the dermis layer, extracts it in the ionic liquid into which carbon dioxide is introduced, and removes the cells. Compared with the traditional chemical, biological and other methods for removing cells, some key substances, such as glycoproteins and growth factors, may be denatured or removed due to the surface activity of detergents. The method for removing cells of the present invention has excellent biocompatibility, low immunogenicity and biological activity. CO2 is usually non-polar. After being introduced into the ionic liquid, some polar substances that are usually difficult to dissolve in non-polar solvents can be dissolved. CO2 penetrates into the tissue and uses its dissolving ability to dissolve some components in the cell, thereby achieving the removal of cell contents. In addition, CO2 can increase the fluidity of the cell membrane, accelerate the rupture of the cell membrane, release the cell contents, and further promote the decellularization process. Since it does not involve the use of chemical reagents, DNA can be removed while retaining its skeleton structure to a large extent. At the same time, the participation of ionic liquids can also assist in removing all cell components in the tissue, greatly improving the efficiency of decellularization.
[0029] However, the acellular dermal matrix obtained by this method still contains a small amount of xenoantigens (such as α-Gal antigen) which can cause a strong xenoimmune response. In the present invention, α-galactosidase is used to remove α-Gal antigen, and trypsin is used to remove other protein antigens, thereby greatly reducing the inflammatory response caused by the obtained product.
[0030] In addition, the present invention compounds hyaluronic acid and antimicrobial peptides to obtain a composite material having both anti-infection and regeneration and repair functions, and fixes them together with ferulic acid on the antigen-free acellular dermal matrix, thereby greatly improving the anti-inflammatory, antibacterial and anti-infection effects of the material, reducing the occurrence of immune response, reducing redness and swelling, and being less prone to allergic reactions.
[0031] However, the material prepared in this way still has the problems of fast and uncontrollable degradation rate and poor mechanical properties. The inventors unexpectedly found that in the process of activation using NHS and EDC, the addition of EDC and NHS can also induce catalytic intramolecular / intermolecular cross-linking of collagen in the decellularized matrix material, improve its resistance to enzymatic hydrolysis, and improve the cross-linking of the material. The activator not only has good biocompatibility, but also regulates its degradation rate, thereby solving the problem of fast and uncontrollable degradation rate of non-cross-linked materials and improving the mechanical strength of the product.
[0032] In addition, the acellular matrix material prepared by the present invention can also be degraded to produce glycyl-histidyl-lysine tripeptide, which also has the effect of promoting the synthesis of collagen, mucopolysaccharide and proteoglycan, stimulating proline enzyme activity, promoting angiogenesis and other biological functions, and accelerating wound healing. DETAILED DESCRIPTION
[0033] The technical solutions in the embodiments of the present invention are described clearly and completely below. Obviously, the described embodiments are only part of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the present invention.
[0034] α-Galactosidase, 10,000 U / g, was purchased from Merck Life Science; trypsin, 5000 U / g, was purchased from Merck Life Science; hyaluronic acid, >99%, was purchased from Xi'an Pris Bioengineering Co., Ltd.; antimicrobial peptides were purchased from Hubei Weideli Chemical Technology Co., Ltd.
[0035] 1-Propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate were purchased from MacLean Reagent.
[0036] Example 1
[0037] This embodiment provides a method for preparing a cell-free matrix material, which specifically comprises the following steps:
[0038] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 2% sodium hydroxide solution for 10 hours to obtain a pretreated pigskin material;
[0039] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, wherein the solid-liquid ratio of the pretreated pigskin material to the ionic liquid was 1:7 g / mL, carbon dioxide was introduced at a ventilation rate of 20 mL / min, stirred for 2 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0040] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:3;
[0041] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 3 g of α-galactosidase and 2 g of trypsin were added, the mixture was heated to 35°C, and the mixture was enzymatically hydrolyzed for 4 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0042] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 4 g EDC and 2 g NHS were added, activated at 20°C for 30 min, 5 g antimicrobial peptide was added, stirred for 12 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0043] S5. Preparation of decellularized matrix material: 2 g of ferulic acid and 12 g of deantigenized decellularized dermal matrix were mixed and added into 200 mL of water, 6 g of EDC and 3 g of NHS were added, activated at 0°C for 30 min, 7 g of hyaluronic acid / antimicrobial peptide complex was added, stirred and reacted for 20 h, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0044] Example 2
[0045] This embodiment provides a method for preparing a cell-free matrix material, which specifically comprises the following steps:
[0046] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 4% sodium hydroxide solution for 3 hours to obtain a pretreated pigskin material;
[0047] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, wherein the solid-liquid ratio of the pretreated pigskin material to the ionic liquid was 1:10 g / mL, carbon dioxide was introduced at a ventilation rate of 30 mL / min, stirred for 1 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0048] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:5;
[0049] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 5 g of α-galactosidase and 3 g of trypsin were added, the mixture was heated to 38°C, and the mixture was hydrolyzed for 2 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0050] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 6 g EDC and 3 g NHS were added, activated at 25°C for 60 min, 7 g antimicrobial peptide was added, stirred for 15 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0051] S5. Preparation of decellularized matrix material: 4 g of ferulic acid and 15 g of deantigenized decellularized dermal matrix were mixed and added into 200 mL of water, 8 g of EDC and 4 g of NHS were added, activated at 4°C for 50 min, 9 g of hyaluronic acid / antimicrobial peptide complex was added, stirred for 24 h, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0052] Example 3
[0053] This embodiment provides a method for preparing a cell-free matrix material, which specifically comprises the following steps:
[0054] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0055] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0056] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0057] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 4 g of α-galactosidase and 2.5 g of trypsin were added, the mixture was heated to 37°C, and the mixture was enzymatically hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0058] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0059] S5. Preparation of decellularized matrix material: Mix 3g of ferulic acid and 13g of deantigenized decellularized dermal matrix and add into 200mL of water, add 7g of EDC and 3.5g of NHS, activate and react at 2℃ for 40min, add 8g of hyaluronic acid / antimicrobial peptide complex, stir and react for 22h, dialyze, and freeze-dry to obtain decellularized matrix material.
[0060] Comparative Example 1
[0061] Compared with Example 3, the difference is that no carbon dioxide is introduced in step S2.
[0062] The details are as follows:
[0063] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0064] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, stirred for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0065] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0066] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 4 g of α-galactosidase and 2.5 g of trypsin were added, the mixture was heated to 37°C, and the mixture was enzymatically hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0067] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0068] S5. Preparation of decellularized matrix material: Mix 3g of ferulic acid and 13g of deantigenized decellularized dermal matrix and add into 200mL of water, add 7g of EDC and 3.5g of NHS, activate and react at 2℃ for 40min, add 8g of hyaluronic acid / antimicrobial peptide complex, stir and react for 22h, dialyze, and freeze-dry to obtain decellularized matrix material.
[0069] Comparative Example 2
[0070] Compared with Example 3, the difference is that no α-galactosidase is added in step S3.
[0071] The details are as follows:
[0072] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0073] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0074] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0075] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 6.5 g of trypsin was added, the mixture was heated to 37°C, and the mixture was hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0076] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0077] S5. Preparation of decellularized matrix material: Mix 3g of ferulic acid and 13g of deantigenized decellularized dermal matrix and add into 200mL of water, add 7g of EDC and 3.5g of NHS, activate and react at 2℃ for 40min, add 8g of hyaluronic acid / antimicrobial peptide complex, stir and react for 22h, dialyze, and freeze-dry to obtain decellularized matrix material.
[0078] Comparative Example 3
[0079] Compared with Example 3, the difference is that trypsin is not added in step S3.
[0080] The details are as follows:
[0081] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0082] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0083] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0084] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 6.5 g of α-galactosidase was added, the mixture was heated to 37°C, and the mixture was hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0085] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0086] S5. Preparation of decellularized matrix material: Mix 3g of ferulic acid and 13g of deantigenized decellularized dermal matrix and add into 200mL of water, add 7g of EDC and 3.5g of NHS, activate and react at 2℃ for 40min, add 8g of hyaluronic acid / antimicrobial peptide complex, stir and react for 22h, dialyze, and freeze-dry to obtain decellularized matrix material.
[0087] Comparative Example 4
[0088] Compared with Example 3, the difference is that step S3 is not performed.
[0089] The details are as follows:
[0090] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0091] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0092] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0093] S3. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0094] S4. Preparation of decellularized matrix material: 3 g of ferulic acid and 13 g of decellularized dermal matrix were mixed and added into 200 mL of water, 7 g of EDC and 3.5 g of NHS were added, activated at 2°C for 40 min, 8 g of hyaluronic acid / antimicrobial peptide complex was added, stirred for 22 h, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0095] Comparative Example 5
[0096] Compared with Example 3, the difference is that no hyaluronic acid / antimicrobial peptide complex is added in step S5.
[0097] The details are as follows:
[0098] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0099] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0100] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0101] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 4 g of α-galactosidase and 2.5 g of trypsin were added, the mixture was heated to 37°C, and the mixture was enzymatically hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0102] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0103] S5. Preparation of decellularized matrix material: 11 g of ferulic acid was mixed into 200 mL of water, 7 g of EDC and 3.5 g of NHS were added, activated at 2°C for 40 min, 13 g of antigen-free decellularized dermal matrix was added, stirred for 22 h, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0104] Comparative Example 6
[0105] Compared with Example 3, the difference is that no ferulic acid is added in step S5.
[0106] The details are as follows:
[0107] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0108] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0109] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0110] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 4 g of α-galactosidase and 2.5 g of trypsin were added, the mixture was heated to 37°C, and the mixture was enzymatically hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0111] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0112] S5. Preparation of decellularized matrix material: 13 g of deantigenized decellularized dermal matrix was mixed into 200 mL of water, 7 g of EDC and 3.5 g of NHS were added, activated at 2°C for 40 min, 11 g of hyaluronic acid / antimicrobial peptide complex was added, stirred for 22 h, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0113] Comparative Example 7
[0114] Compared with Example 3, the difference is that NHS and EDC are not added in step S5.
[0115] The details are as follows:
[0116] S1. Pretreatment of pigskin: The pigskin was cleaned, depilated, and washed to remove the epidermal stratum corneum and subcutaneous fat layer, and the dermis was cut into appropriate sizes and immersed in a 3% sodium hydroxide solution for 5 hours to obtain a pretreated pigskin material;
[0117] S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, the solid-liquid ratio of the pretreated pigskin material and the ionic liquid was 1:8 g / mL, carbon dioxide was introduced, the ventilation volume was 25 mL / min, the stirring treatment was performed for 1.5 h, dialyzed, and freeze-dried to obtain a decellularized dermal matrix;
[0118] The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:4;
[0119] S3. Enzymatic hydrolysis: 100 g of acellular dermal matrix was added to 500 mL of water, 4 g of α-galactosidase and 2.5 g of trypsin were added, the mixture was heated to 37°C, and the mixture was enzymatically hydrolyzed for 3 h, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix;
[0120] S4. Preparation of hyaluronic acid / antimicrobial peptide complex: 10 g hyaluronic acid was added to 200 mL water, 5 g EDC and 2.5 g NHS were added, activated at 22°C for 45 min, 6 g antimicrobial peptide was added, stirred for 13 h, dialyzed, and freeze-dried to obtain a hyaluronic acid / antimicrobial peptide complex;
[0121] S5. Preparation of decellularized matrix material: 3 g of ferulic acid and 13 g of antigen-free decellularized dermal matrix were mixed and added into 200 mL of water, and 8 g of hyaluronic acid / antimicrobial peptide complex was added. The mixture was stirred for 22 h, dialyzed, and freeze-dried to obtain the decellularized matrix material.
[0122] Test Example 1CCK-8 eukaryotic cell toxicity assay
[0123] Deionized water was used to prepare 0.5 wt % of the decellularized matrix material solution prepared in Examples 1-3 or Comparative Examples 1-7.
[0124] HaCaT or NIH-3T3 cells were digested, centrifuged, and counted. 4 The cells were inoculated into a 96-well plate at a density of 1 / well and cultured at 37°C until the cell confluence rate was 70%-80%. 200 μL of serum-free DMEM (MEM culture medium for HaCaT cells) was added to the tube, and 10 μL of the decellularized matrix material solution was added. The cells were incubated at 37°C for 2 h. DMEM containing 20% fetal bovine serum was added, mixed, and then transferred to a 96-well plate. The cells were cultured for 24 h. CCK-8 solution was added and incubated at 37°C for 1.5 h. D 450 nm value, and the blank group (deionized water) was used as the control group to calculate the relative cell viability (%). The results are shown in Table 1.
[0125] Table 1
[0126] Group Relative cell viability of HaCaT cells (%) Relative cell viability of NIH-3T3 cells (%) Blank Group 100 100 Example 1 102 104 Example 2 104 105 Example 3 105 107 Comparative Example 1 101 102 Comparative Example 2 97 99 Comparative Example 3 100 101 Comparative Example 4 94 96 Comparative Example 5 98 96 Comparative Example 6 95 97 Comparative Example 7 99 101
[0127] It can be seen from the above table that the cytotoxicity of the decellularized matrix materials prepared in Examples 1-3 of the present invention is very low.
[0128] Test Example 2 Type I collagenase degradation experiment
[0129] The decellularized matrix material prepared in Example 1-3 or Comparative Example 1-7 was placed in a centrifuge tube, 1 mg / mL of type I collagenase solution (purchased from Wuxi Xinrun Biotechnology Co., Ltd.) was added in proportion, and the tube was placed in a constant temperature culture oscillator for reaction (37±0.1°C, 120 r / min). The samples were taken out at 12, 24, and 48 h (5 samples at each sampling point), dried, and weighed, and the degradation rate was calculated. At the same time, the content of hydroxyproline in the degradation solution at the sampling time point was detected, and the turbidity of the degradation solution was observed.
[0130] Degradation rate = mass before degradation - mass after degradation / mass before degradation × 100%
[0131] The results are shown in Table 2.
[0132] Table 2
[0133]
[0134]
[0135] It can be seen from the above table that the acellular matrix materials prepared in Examples 1-3 of the present invention are degradable and have a suitable degradation rate.
[0136] Test Example 3 Mechanical Properties Test
[0137] The decellularized matrix materials prepared in Examples 1-3 or Comparative Examples 1-7 were cut into 50 mm×4 mm rectangles, and the tensile strength and elongation at break of the samples were tested. The results are shown in Table 3.
[0138] Table 3
[0139]
[0140]
[0141] It can be seen from the above table that the mechanical properties of the decellularized matrix materials prepared in Examples 1-3 of the present invention are good.
[0142] Test Example 4 Anti-inflammatory Experiment
[0143] Preparation of sample solution: Prepare acellular matrix material solution with 0.36wt% NaCl solution at a concentration of 0.5wt%. Rat blood was centrifuged at 4000r / min for 15min, and the red blood cells obtained by washing with 0.85% sodium chloride solution (pH=7.2) were made into red blood cell suspension (10% v / v) for anti-inflammatory activity determination. Using distilled water as a control, 2mL of sample solution, 1mL0.15mol / L phosphate buffer (pH=7.4) and 0.5mL of red blood cell suspension were mixed and treated, and the obtained mixture was incubated at 37°C for 30min, and then centrifuged at 4000r / min for 15min. The supernatant was taken and its hemoglobin was measured by 560nm spectrophotometry. Calculation of red blood cell membrane stability (%):
[0144] Red blood cell membrane stability (%) = (1-A 样本 / A 对照 )×100%
[0145] Diclofenac at the same concentration was used as a positive control drug.
[0146] The results are shown in Table 4.
[0147] Table 4
[0148]
[0149]
[0150] Diclofenac is an anti-inflammatory drug and can be used as a positive control. As can be seen from the above table, the acellular matrix materials prepared in Examples 1-3 of the present invention have good anti-inflammatory properties.
[0151] Test Example 5 Determination of Cellular NO Content
[0152] After counting the number of RAW264.7 macrophages in the logarithmic growth phase, the cell density was adjusted to 2×10 5 / mL. The cells were plated in a 6-well plate, 2mL per well. After the cells adhered to the wall, the decellularized matrix material (0.5mg / L) and LPS (0.5μg / L) prepared in Example 1-3 or Comparative Example 1-7 were given. After 24h at 37°C and 5% CO2, 50μL of the cell supernatant from each group was collected and added to a 96-well plate, 50μL per well. Then, 50μL of GriessReagentⅠ was added, and the reaction was carried out in a 37°C incubator for 10min. Then, 50μL of GriessReagentⅡ was added to each well, and the mixture was mixed evenly by oscillation. After reacting in the dark at 37°C for 10min, the absorbance of each group was detected at a wavelength of 540nm. The control wells were replaced with deionized water instead of supernatant. The blank group was not added with decellularized matrix material and LPS, and the positive group was replaced with dexamethasone instead of decellularized matrix material.
[0153] NO content=[1-(A 给药孔 -A 对照孔 ) / A 对照孔 )]×100%
[0154] The results are shown in Table 5.
[0155] Table 5
[0156]
[0157]
[0158] It can be seen from the above table that the acellular matrix materials prepared in Examples 1-3 of the present invention have a good effect of inhibiting the secretion of inflammatory factors by stimulating macrophages.
[0159] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims
1. A method for preparing a cell-free matrix material, characterized in that: After pretreatment, the pig skin is decellularized in an ionic liquid into which carbon dioxide is introduced, surface antigens are removed by enzymatic hydrolysis, and the pig skin is reacted with ferulic acid and hyaluronic acid / antimicrobial peptide complex to obtain a decellularized matrix material.
2. The preparation method according to claim 1, characterized in that: The following steps are involved: S1. Pretreatment of pigskin: The pigskin is washed, depilated, cleaned, the epidermal stratum corneum and subcutaneous fat layer are removed, the dermis is cut into appropriate sizes, and soaked and shaken with 2-4% sodium hydroxide for 3-10 hours to obtain a pretreated pigskin material; S2. Decellularization: adding the pretreated pig skin material to the ionic liquid, introducing carbon dioxide, stirring, dialyzing, and freeze-drying to obtain a decellularized dermal matrix; S3. Enzymatic treatment: adding the acellular dermal matrix to water, adding α-galactosidase and trypsin, heating for enzymatic hydrolysis, filtering, washing, and drying to obtain the antigen-free acellular dermal matrix; S4. Preparation of hyaluronic acid / antimicrobial peptide complex: adding hyaluronic acid to water, adding EDC and NHS, activating the reaction, adding antimicrobial peptide, stirring the reaction, dialyzing, freeze-drying, and preparing the hyaluronic acid / antimicrobial peptide complex; S5. Preparation of decellularized matrix material: ferulic acid and deantigenized decellularized dermal matrix are mixed and added into water, EDC and NHS are added to activate the reaction, hyaluronic acid / antimicrobial peptide complex is added, stirred for reaction, dialyzed, and freeze-dried to obtain the decellularized matrix material.
3. The preparation method according to claim 2, characterized in that: The solid-liquid ratio of the pretreated pigskin material and the ionic liquid in step S2 is 1:7-10 g / mL, the ventilation volume of the carbon dioxide is 20-30 mL / min, the stirring treatment time is 1-2 h, and the ionic liquid is selected from at least one of acetic acid-3-methylimidazolium hexafluorophosphate, 1-propyl-3-methylimidazolium hexafluorophosphate, boron pentafluoride anthraquinone ionic liquid, N-butylpyridinium tetrafluoroborate, 4-carbamimidazolidine hydrochloride, pyridine p-toluenesulfonate, 1-butyl-2,3-dimethylimidazolium hexafluorophosphate, and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate.
4. The preparation method according to claim 3, characterized in that: The ionic liquid is a mixture of 1-propyl-3-methylimidazolium hexafluorophosphate and 1-butyl-2,3-dimethylimidazolium trifluoromethanesulfonate, with a mass ratio of 10:3-5.
5. The preparation method according to claim 2, characterized in that: In step S3, the mass ratio of the acellular dermal matrix, α-galactosidase and trypsin is 100:3-5:2-3, the temperature of the heating enzymatic hydrolysis is 35-38° C., and the time is 2-4 h.
6. The preparation method according to claim 2, characterized in that: In step S4, the mass ratio of hyaluronic acid, EDC, NHS and antimicrobial peptide is 10:4-6:2-3:5-7, the temperature of the activation reaction is 20-25°C, the time is 30-60min, and the stirring reaction time is 12-15h.
7. The preparation method according to claim 2, characterized in that: In step S5, the mass ratio of ferulic acid, antigen-free acellular dermal matrix, EDC, NHS, and hyaluronic acid / antimicrobial peptide complex is 2-4:12-15:6-8:3-4:7-9, the activation reaction temperature is 0-4°C, the time is 30-50min, and the stirring reaction time is 20-24h.
8. The preparation method according to claim 2, characterized in that: The specific steps include: S1. Pretreatment of pigskin: The pigskin is washed, depilated, cleaned, the epidermal stratum corneum and subcutaneous fat layer are removed, the dermis is cut into appropriate sizes, and soaked and shaken with 2-4% sodium hydroxide for 3-10 hours to obtain a pretreated pigskin material; S2. Decellularization: The pretreated pigskin material was added to the ionic liquid, wherein the solid-liquid ratio of the pretreated pigskin material to the ionic liquid was 1:7-10 g / mL, carbon dioxide was introduced, the ventilation volume was 20-30 mL / min, the treatment was stirred for 1-2 h, dialyzed, and freeze-dried to obtain acellular dermal matrix; S3. Enzymatic hydrolysis: 100 parts by weight of the acellular dermal matrix is added to water, 3-5 parts by weight of α-galactosidase and 2-3 parts by weight of trypsin are added, heated to 35-38° C., enzymatic hydrolysis is performed for 2-4 hours, filtered, washed, and dried to obtain an antigen-free acellular dermal matrix; S4. Preparation of hyaluronic acid / antimicrobial peptide complex: add 10 parts by weight of hyaluronic acid to water, add 4-6 parts by weight of EDC and 2-3 parts by weight of NHS, activate and react at 20-25°C for 30-60 minutes, add 5-7 parts by weight of antimicrobial peptide, stir and react for 12-15 hours, dialyze, and freeze-dry to obtain a hyaluronic acid / antimicrobial peptide complex; S5. Preparation of decellularized matrix material: Mix 2-4 parts by weight of ferulic acid and 12-15 parts by weight of de-antigenized decellularized dermal matrix and add into water, add 6-8 parts by weight of EDC and 3-4 parts by weight of NHS, activate and react at 0-4°C for 30-50 min, add 7-9 parts by weight of hyaluronic acid / antimicrobial peptide complex, stir and react for 20-24 h, dialyze, and freeze-dry to obtain the decellularized matrix material.
9. A decellularized matrix material obtained by the preparation method according to any one of claims 1 to 8.
10. Use of the decellularized matrix material according to claim 9 in preparing medical beauty products.
Citation Information
Cited By
Composition containing adipose-derived stem cells as well as preparation method and application of composition
CN119925704A
A composition containing adipose-derived stem cells, its preparation method and applications
CN119925704B
